ED-HEART for HEART
Emergency Department Healthcare Education Assessment and Response for Teen Relationships: A Pilot Feasibility Study
See full descriptionAbout the trial for HEART
Treatment Groups
This trial involves 2 different treatments. ED-HEART is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Eligibility
This trial is for patients born any sex aged 65 and younger. There is one eligibility criterion to participate in this trial as listed below.
Approximate Timelines
Measurement Requirements
This trial is evaluating whether ED-HEART will improve 1 primary outcome and 2 secondary outcomes in patients with HEART. Measurement will happen over the course of 12 weeks.
Who is running the study
Principal InvestigatorPatient Q & A Section
What are the signs of heart?
Heart symptoms are commonly reported, even on health visits. Patient-physician communication in regards to symptomatology often falls short. Even if there are no symptoms on an examination or during an electrocardiogram, an emphasis must be placed on symptomatology and evaluation of patient health awareness in light of their heart condition.
What is heart?
The human cardiovascular system is complex and includes 4 basic body systems: 1) Circulatory system; 2) Endocrine system; 3) Nervous system; and 4) Lymphoid system. Each part is an intelligent and independent organ that regulates and coordinates the workings of the whole.\n
Can heart be cured?
Cardiovascular diseases are the leading cause of premature mortality around the globe. Recent findings provide no evidence that regenerative medicine or radical cell therapies could be used as a complementary or alternative to current treatments for heart diseases.
What are common treatments for heart?
Heart may be complicated by a variety of cardiac diseases or arrhythmia syndromes. Common treatments include preventive and curative cardiac surgery, cardiopulmonary exercise testing, heart catheterization, and percutaneous coronary intervention. Treatment for congenital heart defects may include surgery, catheterization, or pacemaker placement. Pharmacological treatments, including beta receptor antagonists, ACE inhibitors, and statins, are common. Cardiac devices and implantable devices may be utilized through surgery or catheter placement. Cardiac conditions may be corrected through open heart surgery or endoscopic cardiopulmonary bypass.
What causes heart?
Our initial analysis showed that the heart has a major role in the development of other organs. Since the heart is so much more complex than just an organ with circulation, we have used a model called the 'heart model of development' to take things a step further. The heart model is a computational model of whole organ development that gives a very detailed description of normal and pathological development.
How many people get heart a year in the United States?
About 700,000 patients with stable coronary artery disease in the United States have at least one occasion of a [heart attack] every year. On the other hand, an estimated 200,000 patients would have a [heart attack] every year if they were to be treated like those in the United States but without knowing about their underlying coronary artery disease. Clearly, strategies to prevent and treat [heart disease] among those with significant coronary artery disease should be improved.
Does heart run in families?
Findings from a recent study, no significant relationship between ischemic heart disease status or familial risk factors and the occurrence of cardiac symptoms or disease was found.
Does ed-heart improve quality of life for those with heart?
The ED-heart program had a small but statistically significant positive effect on HRQOL scores for patients with NYHA Class III and IV HF. However, the clinical relevance of this small improvement is questionable.
Have there been other clinical trials involving ed-heart?
More research needs to be done to more accurately determine how to use the ed-heart. Although it looks promising, there is still much research that needs to be done for this device as well.[power]
What is ed-heart?
This novel cardiomyopathy was due to myocardial edema, which develops in hypertrophic and dilated cardiomyopathies, especially after exposure to elevated levels of systemic catecholamines. Clinical and pathological data were consistent with an etiology of "ed-heart syndrome" that was probably the result of the increased ed-stress response. These are compelling arguments for ed to be a cardinal pathogenic factor causing cardiac dysfunction.
What is the latest research for heart?
‘What is now known about heart’? Heart attacks are more common in the older you are. A heart attack can be life-threatening, and people who survive a coronary artery rupture have a 1.5 fold increased risk of death in a year. People with diabetes have a more than double increased risk of dying of a heart attack. heart disease is a serious problem globally affecting billions of people. A heart attack was listed as the number 1 cause of mortality in the latest "Global Burden of Disease Study". Cardiovascular disease accounts for over 30% of all deaths worldwide.
What does ed-heart usually treat?
The study results indicated that, in general, patients with congestive heart failure or ejection fraction less than or equal to 40% undergoing treatment for ed-heart had a greater baseline EF. However, despite being at higher risk when entering ED, baseline EF in ED-heart groups of patients is similar to CHF patients with an EF above 40%. ED-heart patients requiring the placement of a ventricular assist device may have an increased risk of death and need for further heart transplantation.